{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:36:50Z","timestamp":1791052610796,"version":"4.1.0"},"reference-count":166,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Learning Objectives<\/jats:title><jats:p>After completing this course, the reader should be able to: Use current practice methods in the diagnosis of pheochromocytomas.Employ current practice methods in the treatment of pheochromocytomas.Evaluate the current molecular research that contributes to the treatment of pheochromocytomas.<\/jats:p><jats:p>CME This article is available for continuing medical education credit at CME.TheOncologist.com<\/jats:p><jats:p>Pheochromocytomas are rare catecholamine-secreting tumors that arise from chromaffin tissue within the adrenal medulla and extra-adrenal sites. Because of the excess secretion of hormones, these tumors often cause debilitating symptoms and a poor quality of life. While medical management plays a significant role in the treatment of pheochromocytoma patients, surgical excision remains the only cure. Improved medical management and surgical techniques and an increased understanding of hereditary disease have improved the outcome of pheochromocytoma patients with benign disease; however, the outcome of patients with malignant disease remains poor. In this review, we discuss the presentation, diagnosis, management, and future directions in the management of this disease.<\/jats:p><\/jats:sec>","DOI":"10.1634\/theoncologist.2008-0043","type":"journal-article","created":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T01:43:56Z","timestamp":1215740636000},"page":"779-793","source":"Crossref","is-referenced-by-count":154,"title":["Pheochromocytoma: Current Approaches and Future Directions"],"prefix":"10.1093","volume":"13","author":[{"given":"Joel T.","family":"Adler","sequence":"first","affiliation":[{"name":"a Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goswin Y.","family":"Meyer-Rochow","sequence":"additional","affiliation":[{"name":"b Endocrine Surgical Unit, University of Sydney, Royal North Shore Hospital, New South Wales, Australia"},{"name":"c Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[{"name":"a Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana E.","family":"Benn","sequence":"additional","affiliation":[{"name":"c Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Robinson","sequence":"additional","affiliation":[{"name":"c Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, New South Wales, Australia"},{"name":"d Department of Endocrinology, University of Sydney, Royal North Shore Hospital, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Sippel","sequence":"additional","affiliation":[{"name":"a Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan B.","family":"Sidhu","sequence":"additional","affiliation":[{"name":"b Endocrine Surgical Unit, University of Sydney, Royal North Shore Hospital, New South Wales, Australia"},{"name":"c Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,10]]},"reference":[{"key":"2021122208462795300_R1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF01938677","article-title":"Ein Fall von doppelseitigem, v\u00f6llig latent verlaufenen Nebennierentumor und gleichzeitiger Nephritis mit Ver\u00e4nderungen am Circulationsapparat und Retinitis","volume":"103","author":"Fr\u00e4nkel","year":"1886","journal-title":"Arch Pathol Anat Physiol Klin Med"},{"key":"2021122208462795300_R2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/canjclin.34.2.93","article-title":"A case of bilateral completely latent adrenal tumor and concurrent nephritis with changes in the circulatory system and retinitis: Felix Frankel, 1886","volume":"34","author":"Classics in oncology","year":"1984","journal-title":"CA Cancer J Clin"},{"key":"2021122208462795300_R3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005792-199101000-00004","article-title":"A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience","volume":"70","author":"Stein","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"2021122208462795300_R4","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1445-2197.2002.02454.x","article-title":"Changing pattern of adrenalectomy at a tertiary referral centre 1970\u20132000","volume":"72","author":"Sidhu","year":"2002","journal-title":"ANZ J Surg"},{"key":"2021122208462795300_R6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM198411153112007","article-title":"Current concepts. Pheochromocytoma: Diagnosis, localization and management","volume":"311","author":"Bravo","year":"1984","journal-title":"N Engl J Med"},{"key":"2021122208462795300_R7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJM200205093461911","article-title":"Pheochromocytoma\u2014death of an axiom","volume":"346","author":"Dluhy","year":"2002","journal-title":"N Engl J Med"},{"key":"2021122208462795300_R8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N Engl J Med"},{"key":"2021122208462795300_R9","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/jc.2004-1398","article-title":"Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma","volume":"90","author":"Amar","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.amjhyper.2005.06.026","article-title":"The vagaries of pheochromocytomas","volume":"18","author":"Manger","year":"2005","journal-title":"Am J Hypertens"},{"key":"2021122208462795300_R11","first-page":"1","volume-title":"Clinical and Experimental Pheochromocytoma","author":"Manger","year":"1996"},{"key":"2021122208462795300_R12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1500681","article-title":"Circumstances of discovery of phaeochromocytoma: A retrospective study of 41 consecutive patients","volume":"150","author":"Baguet","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2021122208462795300_R13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","article-title":"Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma","volume":"134","author":"Pacak","year":"2001","journal-title":"Ann Intern Med"},{"key":"2021122208462795300_R14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5694\/j.1326-5377.2005.tb06997.x","article-title":"Phaeochromocytoma: Current concepts","volume":"183","author":"Alderazi","year":"2005","journal-title":"Med J Aust"},{"key":"2021122208462795300_R15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: History, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"Manger","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4065\/70.8.757","article-title":"Spells: In search of a cause","volume":"70","author":"Young","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"2021122208462795300_R17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: A multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2021122208462795300_R18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.33549\/physiolres.930129","article-title":"Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytoma","volume":"50","author":"Zelinka","year":"2001","journal-title":"Physiol Res"},{"key":"2021122208462795300_R19","first-page":"1014","article-title":"Incidentally discovered adrenal tumors: An institutional perspective","volume":"110","author":"Herrera","year":"1991","journal-title":"Surgery"},{"key":"2021122208462795300_R20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.0954-6820.1968.tb02445.x","article-title":"On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes","volume":"184","author":"Hedeland","year":"1968","journal-title":"Acta Med Scand"},{"key":"2021122208462795300_R21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1995.tb00531.x","article-title":"Investigation of phaeochromocytoma","volume":"43","author":"Bouloux","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122208462795300_R22","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"2021122208462795300_R23","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1245\/s10434-006-9184-8","article-title":"A dangerous liaison\u2014pheochromocytoma in patients with malignant disease","volume":"13","author":"Weismann","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"2021122208462795300_R24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1067\/msy.2001.118369","article-title":"Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy","volume":"130","author":"Lenert","year":"2001","journal-title":"Surgery"},{"key":"2021122208462795300_R25","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1245\/s10434-007-9426-4","article-title":"Isolated adrenal mass in patients with a history of cancer: Remember pheochromocytoma","volume":"14","author":"Adler","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"2021122208462795300_R26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann Intern Med"},{"key":"2021122208462795300_R27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.12-2-168","article-title":"Adrenal masses in the cancer patient: Surveillance or excision","volume":"12","author":"Mitchell","year":"2007","journal-title":"The Oncologist"},{"key":"2021122208462795300_R28","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122208462795300_R29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2021122208462795300_R30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"key":"2021122208462795300_R31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"2021122208462795300_R32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-2007-970407","article-title":"Genetics and biology of pheochromocytoma","volume":"115","author":"Mannelli","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2021122208462795300_R33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s003450050102","article-title":"Pheochromocytoma: Evaluation, diagnosis, and treatment","volume":"17","author":"Walther","year":"1999","journal-title":"World J Urol"},{"key":"2021122208462795300_R34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"key":"2021122208462795300_R35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"issue":"11 suppl","key":"2021122208462795300_R36","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5","article-title":"von Hippel-Lindau syndrome. A pleomorphic condition","volume":"86","author":"Friedrich","year":"1999","journal-title":"Cancer"},{"key":"2021122208462795300_R37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"2021122208462795300_R38","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jama.1995.03520310062031","article-title":"Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer","volume":"273","author":"Linehan","year":"1995","journal-title":"JAMA"},{"key":"2021122208462795300_R39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.41.1.41","article-title":"Central nervous system involvement in von Hippel-Lindau disease","volume":"41","author":"Filling-Katz","year":"1991","journal-title":"Neurology"},{"key":"2021122208462795300_R40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","article-title":"von Hippel-Lindau disease: Genetic, clinical, and imaging features","volume":"194","author":"Choyke","year":"1995","journal-title":"Radiology"},{"key":"2021122208462795300_R41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00005392-199909010-00004","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: Comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"2021122208462795300_R42","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"2021122208462795300_R43","first-page":"4101","article-title":"Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene","volume":"82","author":"Brauch","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","article-title":"Germline mutations in the vhl gene in patients presenting with phaeochromocytomas","volume":"77","author":"van der Harst","year":"1998","journal-title":"Int J Cancer"},{"key":"2021122208462795300_R45","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R46","first-page":"208","article-title":"The clinical and screening age-at-onset distribution for the MEN-2 syndrome","volume":"44","author":"Easton","year":"1989","journal-title":"Am J Hum Genet"},{"key":"2021122208462795300_R47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(88)91191-9","article-title":"Risk estimation and screening in families of patients with medullary thyroid carcinoma","volume":"1","author":"Ponder","year":"1988","journal-title":"Lancet"},{"key":"2021122208462795300_R48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJM198802253180804","article-title":"The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience","volume":"318","author":"Gagel","year":"1988","journal-title":"N Engl J Med"},{"key":"2021122208462795300_R49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1995.tb01211.x","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group","volume":"238","author":"Modigliani","year":"1995","journal-title":"J Intern Med"},{"key":"2021122208462795300_R50","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: The expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2021122208462795300_R51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ncpendmet0097","article-title":"The genetic basis of pheochromocytoma: Who to screen and how?","volume":"2","author":"Plouin","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2021122208462795300_R52","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1136\/bmj.285.6355.1618","article-title":"Neurofibromatosis, phaeochromocytoma, and somatostatinoma","volume":"285","author":"Cantor","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2021122208462795300_R53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/excr.2000.5138","article-title":"Neurofibromin, a tumor suppressor in the nervous system","volume":"264","author":"Zhu","year":"2001","journal-title":"Exp Cell Res"},{"key":"2021122208462795300_R54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1196\/annals.1353.045","article-title":"Risk-oriented approach to hereditary adrenal pheochromocytoma","volume":"1073","author":"Machens","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2265.2006.02714.x","article-title":"Phaeochromocytoma, new genes and screening strategies","volume":"65","author":"Gimenez-Roqueplo","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122208462795300_R56","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: Implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R57","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R58","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jmg.2007.051045","article-title":"Genetic screening for pheochromocytoma: Should SDHC gene analysis be included?","volume":"44","author":"Mannelli","year":"2007","journal-title":"J Med Genet"},{"key":"2021122208462795300_R59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"key":"2021122208462795300_R60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2273.2007.01378.x","article-title":"The genetics of paragangliomas: A review","volume":"32","author":"Martin","year":"2007","journal-title":"Clin Otolaryngol"},{"key":"2021122208462795300_R61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1353.011","article-title":"Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes","volume":"1073","author":"Benn","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R62","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1590\/S0100-879X2000001000007","article-title":"Adrenal incidentaloma","volume":"33","author":"Arnaldi","year":"2000","journal-title":"Braz J Med Biol Res"},{"key":"2021122208462795300_R63","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/jc.2003-030720","article-title":"Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: The Mayo Clinic experience","volume":"88","author":"Kudva","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R64","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: Measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinchem\/38.4.486","article-title":"Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine","volume":"38","author":"Smythe","year":"1992","journal-title":"Clin Chem"},{"key":"2021122208462795300_R66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.5694\/j.1326-5377.2005.tb06852.x","article-title":"Potential pitfalls in the diagnosis of phaeochromocytoma","volume":"182","author":"Harding","year":"2005","journal-title":"Med J Aust"},{"key":"2021122208462795300_R67","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: Which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"2021122208462795300_R68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-4-2","article-title":"A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma","volume":"4","author":"Sawka","year":"2004","journal-title":"BMC Endocr Disord"},{"key":"2021122208462795300_R69","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R70","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archinte.1992.00400180061009","article-title":"The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls","volume":"152","author":"Sjoberg","year":"1992","journal-title":"Arch Intern Med"},{"key":"2021122208462795300_R71","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9343(88)90261-6","article-title":"Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels","volume":"84","author":"Elliott","year":"1988","journal-title":"Am J Med"},{"key":"2021122208462795300_R72","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7326\/0003-4819-73-5-852","article-title":"Glucagon and pheochromocytoma","volume":"73","author":"Lawrence","year":"1970","journal-title":"Ann Intern Med"},{"key":"2021122208462795300_R73","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.7326\/0003-4819-66-6-1091","article-title":"Glucagon provocative test for pheochromocytoma","volume":"66","author":"Lawrence","year":"1967","journal-title":"Ann Intern Med"},{"key":"2021122208462795300_R74","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archsurg.1951.01250030644004","article-title":"Pheochromocytoma. Anesthetic management during surgical treatment","volume":"62","author":"Apgar","year":"1951","journal-title":"AMA Arch Surg"},{"key":"2021122208462795300_R75","first-page":"1480","article-title":"Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: Analysis of 165 operations at a single center","volume":"86","author":"Plouin","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/jcan.2002.124150","article-title":"Perioperative management of pheochromocytoma","volume":"16","author":"Kinney","year":"2002","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2021122208462795300_R77","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1196\/annals.1353.041","article-title":"Current trends in functional imaging of pheochromocytomas and paragangliomas","volume":"1073","author":"Shulkin","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1991.244","article-title":"Pheochromocytoma: New concepts and future trends","volume":"40","author":"Bravo","year":"1991","journal-title":"Kidney Int"},{"key":"2021122208462795300_R79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/edrv-15-3-356","article-title":"Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma","volume":"15","author":"Bravo","year":"1994","journal-title":"Endocr Rev"},{"key":"2021122208462795300_R80","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma","volume":"229","author":"Goldstein","year":"1999","journal-title":"Ann Surg"},{"key":"2021122208462795300_R81","first-page":"365","article-title":"Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison","volume":"40","author":"Maurea","year":"1996","journal-title":"Q J Nucl Med"},{"key":"2021122208462795300_R82","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00006231-200607000-00006","article-title":"Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: A prospective study","volume":"27","author":"Lumachi","year":"2006","journal-title":"Nucl Med Commun"},{"key":"2021122208462795300_R83","first-page":"173","article-title":"Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: Comparison with CT and MRI","volume":"34","author":"Maurea","year":"1993","journal-title":"J Nucl Med"},{"key":"2021122208462795300_R84","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","article-title":"The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas","volume":"60","author":"Lebuffe","year":"2005","journal-title":"Anaesthesia"},{"key":"2021122208462795300_R85","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1536\/ihj.30.751","article-title":"Effectiveness of long-acting nifedipine in pheochromocytoma","volume":"30","author":"Takahashi","year":"1989","journal-title":"Jpn Heart J"},{"key":"2021122208462795300_R86","first-page":"1599","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas\u2014experience and meta-analysis","volume":"26","author":"Van Der Horst-Schrivers","year":"2006","journal-title":"Anticancer Res"},{"key":"2021122208462795300_R87","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1210\/jc.2003-030235","article-title":"Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma","volume":"88","author":"Ilias","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R88","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00003072-200006000-00010","article-title":"Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma","volume":"25","author":"Fujita","year":"2000","journal-title":"Clin Nucl Med"},{"issue":"suppl 1","key":"2021122208462795300_R89","first-page":"150","article-title":"Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: A personal overview and concluding remarks","volume":"39","author":"Shapiro","year":"1995","journal-title":"Q J Nucl Med"},{"key":"2021122208462795300_R90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","article-title":"Pheochromocytomas: Imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET","volume":"212","author":"Shulkin","year":"1999","journal-title":"Radiology"},{"key":"2021122208462795300_R91","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004728-199603000-00028","article-title":"Malignant pheochromocytoma of the anterior mediastinum: PET findings with [18F]FDG and 82Rb","volume":"20","author":"Neumann","year":"1996","journal-title":"J Comput Assist Tomogr"},{"key":"2021122208462795300_R92","first-page":"1125","article-title":"PET scanning with hydroxyephedrine: An approach to the localization of pheochromocytoma","volume":"33","author":"Shulkin","year":"1992","journal-title":"J Nucl Med"},{"key":"2021122208462795300_R93","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021122208462795300_R94","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/01.rlu.0000247734.67566.0a","article-title":"Multimodality imaging of malignant pheochromocytoma","volume":"31","author":"Esfandiari","year":"2006","journal-title":"Clin Nucl Med"},{"key":"2021122208462795300_R95","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/er.2002-0013","article-title":"Pheochromocytoma: State-of-the-art and future prospects","volume":"24","author":"Bravo","year":"2003","journal-title":"Endocr Rev"},{"key":"2021122208462795300_R96","first-page":"341","article-title":"[Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery]","volume":"30","author":"Sch\u00fctler","year":"1995","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2021122208462795300_R97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2005.01504.x","article-title":"Long-term outcome of a large series of patients surgically treated for pheochromocytoma","volume":"258","author":"Khorram-Manesh","year":"2005","journal-title":"J Intern Med"},{"key":"2021122208462795300_R98","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0748-7983(03)00071-4","article-title":"Phaeochromocytoma\u2014views on current management","volume":"29","author":"Williams","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"2021122208462795300_R99","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0310057X9802600212","article-title":"The preoperative management of phaeochromocytoma","volume":"26","author":"Russell","year":"1998","journal-title":"Anaesth Intensive Care"},{"key":"2021122208462795300_R100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1196\/annals.1353.044","article-title":"Management and treatment of pheochromocytomas and paragangliomas","volume":"1073","author":"Mannelli","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2002.tb04408.x","article-title":"Pheochromocytoma: An approach to antihypertensive management","volume":"970","author":"Bravo","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R102","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/bja\/85.1.44","article-title":"Phaeochromocytoma\u2014recent progress in its management","volume":"85","author":"Prys-Roberts","year":"2000","journal-title":"Br J Anaesth"},{"key":"2021122208462795300_R103","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","article-title":"Metyrosine and pheochromocytoma","volume":"157","author":"Steinsapir","year":"1997","journal-title":"Arch Intern Med"},{"key":"2021122208462795300_R104","first-page":"617","article-title":"Current status of labetalol, the first alpha- and beta-blocking agent","volume":"23","author":"Kanto","year":"1985","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"2021122208462795300_R105","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R106","first-page":"523","article-title":"[Malignant pheochromocytoma: Blood pressure controlled by labetalol]","volume":"75","author":"Sugano","year":"1984","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"issue":"suppl 3","key":"2021122208462795300_R107","first-page":"809","article-title":"Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol","volume":"3","author":"Rosei","year":"1976","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 1","key":"2021122208462795300_R108","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1111\/j.1365-2125.1986.tb02850.x","article-title":"Clinical pharmacological studies with doxazosin","volume":"21","author":"Elliott","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"2021122208462795300_R109","first-page":"195","article-title":"Pheochromocytoma","volume":"6","author":"Bravo","year":"1997","journal-title":"Curr Ther Endocrinol Metab"},{"key":"2021122208462795300_R110","doi-asserted-by":"crossref","first-page":"II66","DOI":"10.1161\/01.HYP.5.4_Pt_2.II66","article-title":"Hemodynamic effects of calcium antagonists. Review","volume":"5","author":"Lehmann","year":"1983","journal-title":"Hypertension"},{"key":"2021122208462795300_R111","first-page":"1149","article-title":"Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: Hemodynamics and free catecholamine assays in ten consecutive patients","volume":"106","author":"Proye","year":"1989","journal-title":"Surgery"},{"key":"2021122208462795300_R112","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1172\/JCI105754","article-title":"Biochemical and pharmacologic effects of alpha-methyltyrosine in man","volume":"47","author":"Engelman","year":"1968","journal-title":"J Clin Invest"},{"key":"2021122208462795300_R113","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-198121020-00001","article-title":"\u03b1-methyl-p-tyrosine: A review of its pharmacology and clinical use","volume":"21","author":"Brogden","year":"1981","journal-title":"Drugs"},{"key":"2021122208462795300_R114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF01476565","article-title":"Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism","volume":"57","author":"Hengstmann","year":"1979","journal-title":"Klin Wochenschr"},{"key":"2021122208462795300_R115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.beem.2006.07.010","article-title":"Laparoscopic adrenalectomy","volume":"20","author":"Gumbs","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2021122208462795300_R116","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.surg.2004.05.058","article-title":"Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas","volume":"136","author":"Shen","year":"2004","journal-title":"Surgery"},{"key":"2021122208462795300_R117","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00268-007-9327-5","article-title":"Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: A single institution review","volume":"32","author":"Ippolito","year":"2008","journal-title":"World J Surg"},{"key":"2021122208462795300_R118","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2007.03.007","article-title":"Laparoscopic surgery is safe for large adrenal lesions","volume":"34","author":"Soon","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"2021122208462795300_R119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01658516","article-title":"Long-term evaluation following resection of apparently benign pheochromocytoma(s)\/paraganglioma(s)","volume":"14","author":"van Heerden","year":"1990","journal-title":"World J Surg"},{"key":"2021122208462795300_R120","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1245\/s10434-007-9489-2","article-title":"Outcomes of pheochromocytoma management in the laparoscopic era","volume":"14","author":"Solorzano","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"2021122208462795300_R121","first-page":"30","article-title":"Feasibility of laparoscopic adrenalectomy for large pheochromocytomas","volume":"11","author":"Dimas","year":"2007","journal-title":"JSLS"},{"key":"2021122208462795300_R122","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0039-6060(96)80056-0","article-title":"Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma","volume":"120","author":"Lee","year":"1996","journal-title":"Surgery"},{"key":"2021122208462795300_R123","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1196\/annals.1353.046","article-title":"Treatment of bilateral pheochromocytoma and adrenal medullary hyperplasia","volume":"1073","author":"Jansson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R124","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","article-title":"Surgical management of hereditary pheochromocytoma","volume":"198","author":"Yip","year":"2004","journal-title":"J Am Coll Surg"},{"key":"2021122208462795300_R125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo-113-1-354","article-title":"Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma","volume":"113","author":"Snavely","year":"1983","journal-title":"Endocrinology"},{"key":"2021122208462795300_R126","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2044.1985.tb10608.x","article-title":"Phaeochromocytoma removal and postoperative hypoglycaemia","volume":"40","author":"Meeke","year":"1985","journal-title":"Anaesthesia"},{"key":"2021122208462795300_R127","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.HYP.29.5.1133","article-title":"Tumor recurrence and hypertension persistence after successful pheochromocytoma operation","volume":"29","author":"Plouin","year":"1997","journal-title":"Hypertension"},{"key":"2021122208462795300_R128","first-page":"147","volume-title":"WHO Classification of Tumours\u2014Pathology and Genetics of Tumours of Endocrine Organs","author":"DeLellis","year":"2004"},{"key":"2021122208462795300_R129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2265.1996.657475.x","article-title":"The diagnosis of malignancy in phaeochromocytoma","volume":"44","author":"Pattarino","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122208462795300_R130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/erc.1.00913","article-title":"Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma","volume":"12","author":"Brouwers","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"2021122208462795300_R131","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1677\/ERC-07-0074","article-title":"The diagnosis and management of malignant phaeochromocytoma and paraganglioma","volume":"14","author":"Chrisoulidou","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"2021122208462795300_R132","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO.1989.7.11.1720","article-title":"Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma","volume":"7","author":"Helman","year":"1989","journal-title":"J Clin Oncol"},{"key":"2021122208462795300_R133","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"2021122208462795300_R134","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/1097-0142(19920601)69:11<2683::AID-CNCR2820691110>3.0.CO;2-M","article-title":"The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma","volume":"69","author":"Nativ","year":"1992","journal-title":"Cancer"},{"key":"2021122208462795300_R135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1196\/annals.1353.058","article-title":"Gene expression profiling of benign and malignant pheochromocytoma","volume":"1073","author":"Brouwers","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R136","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1210\/jc.2007-1253","article-title":"Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy","volume":"92","author":"Thouennon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R137","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s002689900139","article-title":"Clinical spectrum and outcome of functional extraadrenal paraganglioma","volume":"20","author":"O'Riordain","year":"1996","journal-title":"World J Surg"},{"key":"2021122208462795300_R138","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","article-title":"Pheochromocytomas: Can malignant potential be predicted?","volume":"53","author":"John","year":"1999","journal-title":"Urology"},{"key":"2021122208462795300_R139","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11906-004-0044-2","article-title":"Pheochromocytoma: Diagnosis and management update","volume":"6","author":"Manger","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"2021122208462795300_R140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1196\/annals.1353.053","article-title":"Courses of malignant pheochromocytoma: Implications for therapy","volume":"1073","author":"Sisson","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R141","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1677\/erc.1.00829","article-title":"Malignant pheochromocytoma: Current status and initiatives for future progress","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"2021122208462795300_R142","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000074659","article-title":"Biochemical diagnosis of pheochromocytoma","volume":"31","author":"Eisenhofer","year":"2004","journal-title":"Front Horm Res"},{"key":"2021122208462795300_R143","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1055-3207(18)30244-8","article-title":"Benign and malignant pheochromocytoma: Diagnosis, treatment, and follow-up","volume":"7","author":"Kebebew","year":"1998","journal-title":"Surg Oncol Clin N Am"},{"key":"2021122208462795300_R144","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jnci\/93.8.648","article-title":"Radiofrequency ablation: A novel approach for treatment of metastatic pheochromocytoma","volume":"93","author":"Pacak","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"2021122208462795300_R145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2169\/internalmedicine.38.349","article-title":"Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization","volume":"38","author":"Takahashi","year":"1999","journal-title":"Intern Med"},{"key":"2021122208462795300_R146","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF03348026","article-title":"The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): A comprehensive review of 116 reported patients","volume":"20","author":"Loh","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"2021122208462795300_R147","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1043-2760(01)00492-1","article-title":"Radioisotope diagnosis and therapy of malignant pheochromocytoma","volume":"12","author":"Shapiro","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2021122208462795300_R148","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1677\/erc.1.01116","article-title":"Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues","volume":"12","author":"Kaltsas","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"2021122208462795300_R149","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","article-title":"Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine","volume":"109","author":"Averbuch","year":"1988","journal-title":"Ann Intern Med"},{"key":"2021122208462795300_R150","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.2006-1544","article-title":"Clinical review: Current treatment of malignant pheochromocytoma","volume":"92","author":"Scholz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208462795300_R151","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF03345807","article-title":"Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases","volume":"15","author":"Schlumberger","year":"1992","journal-title":"J Endocrinol Invest"},{"key":"2021122208462795300_R152","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdg358","article-title":"Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline","volume":"14","author":"Nakane","year":"2003","journal-title":"Ann Oncol"},{"key":"2021122208462795300_R153","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2169\/internalmedicine.38.433","article-title":"Palliative chemotherapy for malignant pheochromocytoma: Symptomatic palliation of two cases","volume":"38","author":"Iwabuchi","year":"1999","journal-title":"Intern Med"},{"key":"2021122208462795300_R154","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2005.03.6046","article-title":"Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors","volume":"24","author":"Kulke","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122208462795300_R155","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1677\/erc.1.01124","article-title":"The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-Kit or PDGF-R","volume":"13","author":"Gross","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"2021122208462795300_R156","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1568009033481831","article-title":"Clinical development of 17-allylamino, 17-demethoxygeldanamycin","volume":"3","author":"Sausville","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"2021122208462795300_R157","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1353.010","article-title":"Genetic testing in pheochromocytoma: Increasing importance for clinical decision making","volume":"1073","author":"Bornstein","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2021122208462795300_R158","first-page":"171","article-title":"Hereditary paraganglioma\/pheochromocytoma and inherited succinate dehydrogenase deficiency","volume":"63","author":"Favier","year":"2005","journal-title":"Horm Res"},{"key":"2021122208462795300_R159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.cco.0000198017.45982.06","article-title":"Evolving concepts in pheochromocytoma and paraganglioma","volume":"18","author":"Dahia","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"2021122208462795300_R160","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000421-199908000-00008","article-title":"Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy","volume":"22","author":"Sisson","year":"1999","journal-title":"Am J Clin Oncol"},{"key":"2021122208462795300_R161","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jss.2006.02.002","article-title":"ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells","volume":"133","author":"Kappes","year":"2006","journal-title":"J Surg Res"},{"key":"2021122208462795300_R162","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.surg.2006.12.005","article-title":"Lithium ions: A novel treatment for pheochromocytomas and paragangliomas","volume":"141","author":"Kappes","year":"2007","journal-title":"Surgery"},{"key":"2021122208462795300_R163","article-title":"Histone deacetylase inhibitors upregulate notch1 and inhibit growth in pheochromocytoma cells","volume-title":"Surgery","author":"Adler","year":"2008"},{"key":"2021122208462795300_R164","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/hmg\/11.20.2347","article-title":"The pressure rises: Update on the genetics of phaeochromocytoma","volume":"11","author":"Maher","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2021122208462795300_R165","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","article-title":"Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene","volume":"294","author":"Schiavi","year":"2005","journal-title":"JAMA"},{"key":"2021122208462795300_R166","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2008-0043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2008-0043","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/13\/7\/779\/41832107\/oncolo_13_7_779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/13\/7\/779\/41832107\/oncolo_13_7_779.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:21:35Z","timestamp":1738282895000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/13\/7\/779\/6397240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":166,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,7,10]]},"published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2008-0043","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,7,1]]},"published":{"date-parts":[[2008,7,1]]}}}